NeuroSense Therapeutics L... (NRSN)
NASDAQ: NRSN
· Real-Time Price · USD
1.25
0.02 (1.63%)
At close: Oct 03, 2025, 3:59 PM
1.25
0.00%
After-hours: Oct 03, 2025, 07:58 PM EDT
1.63% (1D)
| Bid | 1.23 |
| Market Cap | 30.83M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.66M |
| EPS (ttm) | -0.36 |
| PE Ratio (ttm) | -3.47 |
| Forward PE | -6.15 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 1.25 |
| Volume | 215,013 |
| Avg. Volume (20D) | 645,223 |
| Open | 1.23 |
| Previous Close | 1.23 |
| Day's Range | 1.22 - 1.25 |
| 52-Week Range | 0.80 - 2.60 |
| Beta | 1.59 |
| Ex-Dividend Date | n/a |
About NRSN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRSN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRSN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+16.24%
NeuroSense Therapeutics shares are trading higher ...
Unlock content with
Pro Subscription
1 month ago
+2.8%
NRSN stock has given up its prior gain. NeuroSense Therapeutics shares were trading higher after the company announced a $500,000 private placement.
